Literature DB >> 26974303

Lung Malignancies in HIV Infection.

Keith Sigel1, Robert Pitts1, Kristina Crothers2.   

Abstract

Pulmonary malignancies are a major source of morbidity and mortality in HIV-infected persons. Non-AIDS-defining lung cancers (mostly non-small cell lung cancers) are now a leading cause of cancer death among HIV-infected persons. HIV-associated factors appear to affect the risk of lung cancer and may adversely impact cancer treatment and outcomes. HIV infection also may modify the potential harms and benefits of lung cancer screening with computed tomography. AIDS-defining lung malignancies include pulmonary Kaposi sarcoma and pulmonary lymphoma, both of which are less prevalent with widespread adoption of antiretroviral therapy. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26974303      PMCID: PMC5140273          DOI: 10.1055/s-0036-1578803

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  121 in total

1.  The potential impact of CD4+ T cell activation and enhanced Th1/Th2 cytokine ratio on HIV-1 secretion in the lungs of individuals with advanced AIDS and active pulmonary infection.

Authors:  Pierre-Alain Rubbo; Edouard Tuaillon; Karine Bolloré; Vincent Foulongne; Arnaud Bourdin; Nicolas Nagot; Philippe Van de Perre; Claude Desgranges; Dominique Israël-Biet; Jean-Pierre Vendrell
Journal:  Clin Immunol       Date:  2011-01-27       Impact factor: 3.969

2.  Elevated risk of lung cancer among people with AIDS.

Authors:  Anil K Chaturvedi; Ruth M Pfeiffer; Leonard Chang; James J Goedert; Robert J Biggar; Eric A Engels
Journal:  AIDS       Date:  2007-01-11       Impact factor: 4.177

Review 3.  HIV-associated lung infections and complications in the era of combination antiretroviral therapy.

Authors:  Kristina Crothers; Bruce W Thompson; Kathryn Burkhardt; Alison Morris; Sonia C Flores; Philip T Diaz; Richard E Chaisson; Gregory D Kirk; William N Rom; Laurence Huang
Journal:  Proc Am Thorac Soc       Date:  2011-06

4.  Protease inhibitors exposure is not related to lung cancer risk in HIV smoker patients: a nested case-control study.

Authors:  Mathias Bruyand; Fabien Le Marec; Armelle Lavole; Karen Leffondre; Jean Philippe Spano; Vincent Le Moing; Pierre Tattevin; Laura March; Jacques Cadranel; Fabrice Bonnet; Marguerite Guiguet
Journal:  AIDS       Date:  2015-06-01       Impact factor: 4.177

5.  Trends in cancer risk among people with AIDS in the United States 1980-2002.

Authors:  Eric A Engels; Ruth M Pfeiffer; James J Goedert; Phillip Virgo; Timothy S McNeel; Steven M Scoppa; Robert J Biggar
Journal:  AIDS       Date:  2006-08-01       Impact factor: 4.177

Review 6.  Carcinogenic viruses and solid cancers without sufficient evidence of causal association.

Authors:  Paolo De Paoli; Antonino Carbone
Journal:  Int J Cancer       Date:  2013-01-18       Impact factor: 7.396

7.  Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans.

Authors:  Kristina Crothers; Joseph L Goulet; Maria C Rodriguez-Barradas; Cynthia L Gibert; Kris Ann K Oursler; Matthew Bidwell Goetz; Stephen Crystal; David A Leaf; Adeel A Butt; R Scott Braithwaite; Robin Peck; Amy C Justice
Journal:  AIDS Educ Prev       Date:  2009-06

Review 8.  Primary pulmonary lymphoma.

Authors:  J Cadranel; M Wislez; M Antoine
Journal:  Eur Respir J       Date:  2002-09       Impact factor: 16.671

Review 9.  Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.

Authors:  Oluwatoyin F Gbabe; Charles I Okwundu; Martin Dedicoat; Esther E Freeman
Journal:  Cochrane Database Syst Rev       Date:  2014-08-13

10.  Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells.

Authors:  Cinzia Giagulli; Stefania Marsico; Anna K Magiera; Rosalinda Bruno; Francesca Caccuri; Ines Barone; Simona Fiorentini; Sebastiano Andò; Arnaldo Caruso
Journal:  PLoS One       Date:  2011-03-14       Impact factor: 3.240

View more
  8 in total

Review 1.  HIV and cancer in the Veterans Health Administration System.

Authors:  Keith Sigel; Lesley Park; Amy Justice
Journal:  Semin Oncol       Date:  2019-10-28       Impact factor: 4.929

Review 2.  Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy.

Authors:  Meghan E Fitzpatrick; Ken M Kunisaki; Alison Morris
Journal:  AIDS       Date:  2018-01-28       Impact factor: 4.177

3.  Clinically significant mutations in HIV-infected patients with lung adenocarcinoma.

Authors:  Jonathan Thaler; Carlie Sigel; Mary Beth Beasley; Juan Wisnivesky; Kristina Crothers; Joshua Bauml; Kristen Hysell; Brinda Emu; Laetitia Borsu; Keith Sigel
Journal:  Br J Cancer       Date:  2017-09-21       Impact factor: 7.640

4.  Role of TIM-4 in exosome-dependent entry of HIV-1 into human immune cells.

Authors:  Brian Sims; Anitra L Farrow; Sparkle D Williams; Anju Bansal; Alexandre Krendelchtchikov; Linlin Gu; Qiana L Matthews
Journal:  Int J Nanomedicine       Date:  2017-07-06

5.  Simultaneous presentation of two noninflammatory lung diseases in an HIV-infected patient.

Authors:  Rafael Martínez-Girón; Santiago Martínez-Torre
Journal:  Ann Thorac Med       Date:  2017 Apr-Jun       Impact factor: 2.219

6.  Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells/μl.

Authors:  Chung Yin Kong; Keith Sigel; Steven D Criss; Deirdre F Sheehan; Matthew Triplette; Michael J Silverberg; Claudia I Henschke; Amy Justice; R Scott Braithwaite; Juan Wisnivesky; Kristina Crothers
Journal:  AIDS       Date:  2018-06-19       Impact factor: 4.177

7.  Molecular Changes of Lung Malignancy in HIV Infection.

Authors:  Jianghua Zheng; Lin Wang; Zenghui Cheng; Zenglin Pei; Zhiyong Zhang; Zehuan Li; Xuan Zhang; Dong Yan; Qianlin Xia; Yanling Feng; Yanzheng Song; Weiping Chen; Xiaoyan Zhang; Jianqing Xu; Jin Wang
Journal:  Sci Rep       Date:  2018-09-03       Impact factor: 4.379

8.  Cytopathological analysis of bronchoalveolar lavage fluid in patients with and without HIV infection.

Authors:  Xiang-Mei Chen; Lei Sun; Kun Yang; Jia-Min Chen; Liang Zhang; Xiao-Yi Han; Xingang Zhou; Zhi-Yuan Ma; Man Li; Hong-Xin Zhao; Li-Ming Qi; Peng Wang
Journal:  BMC Pulm Med       Date:  2022-02-08       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.